PL-MLP
N/A
Report date: 2026/01/10 20:00:10
NME
Base Information
Drug NamePL-MLP
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLipomedix Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesLipomedix Pharmaceuticals Inc
Inactive CompaniesN/A
Active Indications
Inactive Indications +[5]
Other Information
ATC CodeN/A
Related LinksN/A